切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (04) : 463 -468. doi: 10.3877/cma.j.issn.1674-6902.2019.04.012

论著

孤立性肺结节危险因素及良恶性预测模型
曹芹1,(), 李雪冰1, 张丽2, 刘珂崎3   
  1. 1. 625000 四川省雅安市人民医院呼吸与危重症医学科
    2. 625000 四川省雅安市人民医院放射科
    3. 625000 四川省雅安市人民医院胸外科
  • 收稿日期:2019-03-19 出版日期:2019-08-20
  • 通信作者: 曹芹

Analysis of risk factors of solitary pulmonary nodules and exploration of predictive model for benign and malignant pulmonary nodules

Qin Cao1,(), Xuebing Li1, Li Zhang2, Keqi Liu3   

  1. 1. Department of Respiratory and Critical Care Medicine, Ya′an People′s Hospital, Ya′an 625000, Sichuan Province, China
    2. Radiology, Ya′an People′s Hospital, Ya′an 625000, Sichuan Province, China
    3. Thoracic Surgery, Ya′an People′s Hospital, Ya′an 625000, Sichuan Province, China
  • Received:2019-03-19 Published:2019-08-20
  • Corresponding author: Qin Cao
引用本文:

曹芹, 李雪冰, 张丽, 刘珂崎. 孤立性肺结节危险因素及良恶性预测模型[J]. 中华肺部疾病杂志(电子版), 2019, 12(04): 463-468.

Qin Cao, Xuebing Li, Li Zhang, Keqi Liu. Analysis of risk factors of solitary pulmonary nodules and exploration of predictive model for benign and malignant pulmonary nodules[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(04): 463-468.

目的

分析孤立性肺结节的危险因素并探讨肺部结节良恶性预测模型。

方法

收集雅安市人民医院2017年1月至2018年8月经胸外科手术切除且有明确病理诊断的112例孤立性肺结节患者的临床资料。回顾性分析其年龄、性别、吸烟史、肿瘤家族史、既往肿瘤史、血清癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、细胞角蛋白19片段(CYFRA21-1),以及肺部结节密度、直径、位置、分叶、毛刺、胸膜凹陷征、血管集束征、空泡征、空气支气管征、钙化等影像学特征。根据病理诊断分为良性、恶性两组,进行单因素分析,将单因素分析中有显著性差异的临床信息纳入Logistic回归分析,筛选出恶性结节的独立危险因素并建立预测模型。

结果

单因数分析中年龄、既往肿瘤史、CEA、CYFRA21-1、结节密度、分叶、毛刺、胸膜凹陷征、血管集束征、空泡征、钙化征有统计学差异(P<0.05)。Logjistic回归分析显示患者年龄、CEA、CYFRA21-1、磨玻璃密度、分叶为恶性结节的独立危险因素。恶性肺部结节的预测模型公式为:Pex/(1+ex),x=-8.816+(3.018×密度)+(0.073×年龄)+(0.482×CEA)+(0.426×CRFRA21-1)+(1.421×分叶)。

结论

患者年龄、血CEA、血CYFRA21-1、磨玻璃密度、分叶为恶性结节的独立危险因素,预测模型对恶性肺结节有较好的敏感性及特异性,诊断准确性较高。

Objective

To analyze the risk factors of solitary pulmonary nodules and establish a predictive model for benign and malignant pulmonary nodules.

Methods

The clinical data of 112 patients with solitary pulmonary nodules, who had a definite pathological diagnosis and underwent thoracic surgery in Ya′an People′s Hospital from January 2017 to August 2018, were reviewed respectively. Their age, gender, smoking history, family history of cancer, past cancer history, serum cancer biomarkers including carcinoembryonic antigen (CEA), neuron specific enolase (NSE) and cytokeratin 19 fragment (CYFRA21-1), and the radiological charateristics including the nodule density, diameter, location, lobulation, burr, pleural indentation, vascular cluster sign, vacuole sign, air information of bronchial sign and calcification sign, were summarized. The patients were divided into two groups according to the pathological diagnosis of their benign or malignant pulmonary nodules. After a univariate analysis, the clinical information with significant differences was chosen for logistic regression analysis and these independent risk factors for malignant pulmonary nodules were screened. Finally, a predicative model for benign and malignant pulmonary nodules was established.

Results

There were significant differences in age, past cancer history, serum CEA and CYFRA21-1, nodule density, lobulation, burr, pleural indentation sign, vascular cluster sign, vacuole sign and calcification sign between the patients with benign and malignant pulmonary nodules (P<0.05). Logistic regression analysis showed that age, CEA, CYFRA21-1, ground glass density and lobulation were independent risk factors for malignant pulmonary nodules. One model was established as following: P=ex/(1+ ex), x=-8.816+ (3.018×density)+ (0.073×age)+ (0.482×CEA)+ (0.426×CRFRA21-1)+ (1.421×lobulation).

Conclusion

Age, CEA, CYFRA21-1, ground glass density and lobulation are independent risk factors for malignant pulmonary nodules. And the predictive model of malignant pulmonary nodules has a better sensitivity and specificity and a high diagnostic accuracy.

表1 良、恶性患者临床特征比较
表2 良、恶性患者影像资料比较
表3 二元logistic分析结果
图1 受试者工作曲线
1
Harzheim D, Eberhardt R, Hoffmann H, et al. The solitary pulmonary nodule[J]. Respiration, 2015, 90(2): 160-172.
2
苏 雷,支修益,张 毅,等. 胸腔镜治疗孤立性肺小结节的分析[J]. 首都医科大学学报,2015, 36(4): 525-528.
3
Manca G, Davin F, Tardelli E, et al. Clinical Impact of Radioguided Localization in the Treatment of Solitary Pulmonary Nodule: A 20-Year Retrospective Analysis. [J]? Clin Nucl Med, 2018, 43 (5): 317-322.
4
Wang Memoli JS, Nietert PJ, et al. Silvestri GA, Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule[J]. Chest, 2012, 142(2): 385-393.
5
周薇薇,郑 荣,邓 颖,等. 2013年四川省肿瘤登记地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤,2018, 27(7): 489-496.
6
Swensen SJ, Silverstrin MD, Iistrup DM, et al. The probability of malignancy in solitary pulmonary nodules:application to small radiologically in determinate odules[J]. Arch Inter Med, 1997, 157(8): 849-855.
7
李 运,陈克忠,隋锡朝,等. 孤立性肺结节良恶性判断数学预测模型的建立[J]. 北京大学学报:医学版,2011, 43(3): 450-454.
8
Gould MK, Ananth L, Bamett pg. A clinicai model to estimate the pretestprobabability of lung cancer in patients with solitary pulmonary nodules[J]. Chest, 2007, 131(2): 383-388.
9
林 洁,唐 坤,殷薇薇,等. PET/CT及其数学预测模型对孤立性肺结节诊断价值的对比研究[J]. 温州医科大学学报,2015, 45(5): 354-358.
10
Yonemori K, Tateishi U, Uno H, et al. Development and validation of diagnostic prediction model for solitary pulmonary nodules[J]. Respirology, 2007, 12(6): 856-862.
11
夏 旭,胡宁东,袁海云,等. 孤立性肺结节病变性质临床鉴别诊断预测模型的初探[J/CD]. 中华肺部疾病杂志(电子版), 2012, 5(3): 265-269.
12
彭笑怒,黄海波,仲崇文,等. 血清肿瘤标志物检测在孤立性肺内结节诊断中的价值[J]. 中国实验诊断学,2009, 13(3): 359-361.
13
Seemann MD, Einerl T, Furst H, et al. An evaluation of the tumor markers, carcino embryonic antigen(CEA), cytokerat in marker(CYFRA21-1)and neuron-specific enolas(NSE)in the differentiation of malignant from benign solitary pulmonary lesions[J]. Lung Cancer, 1999, 26(3): 149.
14
沈德义,沈敏棋,李 炯,等. CYFRA21-1检测对非小细胞肺癌的临床意义[J]. 肿瘤研究与临床,2001, 27(1): 49-50.
15
项杨威,孙益峰,高 文,等. 实性孤立性肺结节良恶性预测模型的建立[J]. 中华医学杂志,2016, 96(17): 1354-1358.
16
李笑莹,刘 芳,车海杰,等. 肿瘤标志物预测孤立性肺结节恶性概率模型的建立与初步评价[J]. 山东大学学报(医学版), 2017, 55(4): 60-64.
17
王 欣,徐跃华,杜紫燕,等. 孤立性肺结节的CT影像学特征及良恶性预测模型的建立[J]. 中华肿瘤杂志,2018, 40(2): 115-120.
18
喻 微,叶 波,续力云,等. 预测恶性孤立性肺结节logistic回归诊断模型的建立[J]. 温州医科大学学报,2017, 47(9): 660-665.
19
姚 羽,徐 婷,林 勇,等. 不同密度恶性孤立性肺结节临床及病理资料分析[J]. 临床肺科杂志,2019, 24(1): 90-94.
20
邱志新,李为民. 328例HRCT表现为孤立性磨玻璃结节肺癌患者的临床、病理及影像学特征分析[J]. 中国呼吸与危重监护杂志,2018, 17(5): 470-476.
21
陈 婧,叶晓 丹,叶剑定,等. 孤立性肺结节良恶性判断的数学预测模型建立与验证[J]. 中国医学计算机成像杂志,2016, 22(6): 573-577.
22
中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺结节诊治中国专家共识(2018年版) [J]. 中华结核和呼吸杂志,2018, 41(10): 763-771.
23
朱 颖,许攀峰,姚亚克,等. 恶性孤立性肺小结节的独立预测因子及预测模型[J]. 中国肿瘤临床,2018, 45(10): 497-502.
24
鲍 彤,肖 飞,郭永庆,等. 对孤立性肺结节恶性概率预测模型的验证、比较和改良[J]. 中国胸心血管外科临床杂志,2018, 26(6): 471-476.
25
McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cacer in pulmonary nodules detected on first screening CT[J]. NEngl J Med, 2013, 369(10): 910-919.
26
Zhang M, Zhou N, Guo Z, et al. Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodules[J]. Thorac Dis, 2015, 7(10): 1833-1834.
27
Herder GL, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography[J]. Chest, 2005, 128(4): 2490-2496.
28
Gibson G, Kumar AR, Steinke K, et al. Risk stratification in the investigation of pulmonary nodules in a high-risk cohort:positron emission tomography/computed outperforms clinical risk prediction algorithms[J]. Interm Med J, 2017, 47(12): 1385-1392.
29
Wang L, Chen Y, Tang K, et al. The value of 18F-FDG PET/CT mathematical prediction model in diagnosis of solitary pulmonary nodules[J]. Biomed Res Int, 2018, 2018: 9453967.
30
Perandini S, Soardi GA, Motton M, et al. Solid pulmonary nodule risk assessment and decision analysis:comparision of four predition models in 285 cases[J]. Eur Radio, 2016, 26(9): 3071-3076.
31
Perandini S, Soardi GA, Motton M, et al. Enhanced characterization of solid solitary pulmonary nodules with Bayesian analysis-based computer-aided diagnosis[J]. World J Radio, 2016, 8(8): 729-734.
[1] 刘欢颜, 华扬, 贾凌云, 赵新宇, 刘蓓蓓. 颈内动脉闭塞病变管腔结构和血流动力学特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 809-815.
[2] 马艳波, 华扬, 刘桂梅, 孟秀峰, 崔立平. 中青年人颈动脉粥样硬化病变的相关危险因素分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 822-826.
[3] 黄应雄, 叶子, 蒋鹏, 詹红, 姚陈, 崔冀. 急性肠系膜静脉血栓形成致透壁性肠坏死的临床危险因素分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 413-421.
[4] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[5] 张再博, 王冰雨, 焦志凯, 檀碧波. 胃癌术后下肢深静脉血栓危险因素的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 475-480.
[6] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[7] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[8] 陈旭渊, 罗仕云, 李文忠, 李毅. 腺源性肛瘘经手术治疗后创面愈合困难的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 82-85.
[9] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[10] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[11] 毛永欢, 仝瀚文, 缪骥, 王行舟, 沈晓菲, 喻春钊. 造口旁疝危险因素预测模型构建[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 682-687.
[12] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[13] 陆猛桂, 黄斌, 李秋林, 何媛梅. 蜂蛰伤患者发生多器官功能障碍综合征的危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1010-1015.
[14] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[15] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
阅读次数
全文


摘要